New drug as potential therapeutic for Asian patients with advanced Cancer
The drug Selinexor blocks specific protein that has been shown to be overexpressed in many types of cancer. Authors in this study evaluated the tolerability and the safety of this […]
A new protein as a target for cancer treatment
Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by Natures Communications and helmed by Associate Professor Polly Chen provides insights […]
Gold nanoparticles – An anticancer strategy for breast cancer patients
Incidence rate for breast cancer has been increasing in females globally. Immunotherapy has recently emerged as a promising anti-cancer strategy for prolonged survival in breast cancer patients. Recently, gold nanoparticles […]
New partnership with NUSMed Clinician Scientist Development Unit (CSDU)
The NUS Yong Loo Lin School of Medicine Clinician Scientist Development Unit (CSDU) provides guidance and training to develop the research careers of budding clinician-scientists in NUHS. Given the shared […]